MetLife launches cancer support benefit

MetLife has introduced a new Cancer Support benefit to help employees with personalized advice and attention from diagnosis to treatment and through recovery. Through a relationship with Private Health Management, a care management company, MetLife will expand its Critical Illness Insurance offering to provide a more robust cancer benefit, including access to top oncology specialists, tech-enabled and expert-led coordination, and patient counseling.

As part of the collaboration, Private Health Management’s team of professionals will work closely with MetLife to ensure that covered policyholders receive individualized counseling and attention, helping them navigate the complexities of cancer treatment and recovery.

MetLife’s Cancer Support benefit will be available to MetLife Critical Illness insureds with covered cancer conditions, beginning January 1, 2026.

“Our new Cancer Support benefit raises the bar in delivering compassionate, expert-led guidance at a time when individuals are facing one of life’s most difficult moments. For employers, it’s a meaningful way to support their employees, offering a benefit that can make a difference in how they navigate the complexities of a cancer diagnosis and improve patient outcomes. As cancer costs continue to rise, this benefit also has been proven to reduce overall medical costs for employees and employers alike.” – Chris Swanker, senior vice president, Group Benefits Products at MetLife.

“MetLife is building a truly comprehensive benefits experience – adding a Cancer Support benefit will be a critical element. At Private Health Management, our mission is to empower patients with the knowledge, resources, and support they need to achieve the best possible outcomes. We are excited to team up with MetLife to bring that promise to more patients in their cancer treatment and recovery journeys.” – Ken Tarkoff, CEO of Private Health Management.